Evidence map›Paper›PMID 42782745›Full record

ArticleCells2026

Adipocyte

Minghui Qin, Fuqiang Li, Mingjie Yang, Lai Wang, Behrooz G Sharifi, Prediman K Shah

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Minghui QinThe Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute Cedars-Sinai Med. Ctr., Los Angeles, CA 90048, USA.
Fuqiang LiThe Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute Cedars-Sinai Med. Ctr., Los Angeles, CA 90048, USA.
Mingjie YangThe Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute Cedars-Sinai Med. Ctr., Los Angeles, CA 90048, USA.
Lai WangThe Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute Cedars-Sinai Med. Ctr., Los Angeles, CA 90048, USA.
Behrooz G SharifiThe Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute Cedars-Sinai Med. Ctr., Los Angeles, CA 90048, USA.ORCID 0000-0002-3877-5907
Prediman K ShahThe Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute Cedars-Sinai Med. Ctr., Los Angeles, CA 90048, USA.

Funding

A hypercholesterolemia-induced immunometabolite in atherosclerosisR01HL160860 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI SHAH, PREDIMAN KRISHAN · 2022 to 2025
$2.5M
The role of GATA3-positive macrophages in cardiovascular pathologiesR01HL160908 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI SHAH, PREDIMAN KRISHAN · 2022 to 2025
$1.7M
National Heart Lung and Blood Institute R01HL160860 and R01HL160908 (to P.K.S.)NHLBI NIH HHS R01 HL160860NHLBI NIH HHS R01 HL160908
6 · The paper itself

Abstract

Adipose tissue dysfunction drives obesity-associated metabolic disease, yet the transcriptional regulators of pathological adipose remodeling remain undefined. Here, we identify adipocyte

Indexed as

AdipocytesAdipose TissueGATA3 Transcription FactorMetabolic DiseasesAdipogenesisAnimalsDiet, High-FatHumansMaleMiceMice, Inbred C57BLObesityGata3 protein, mouseGATA3 Transcription Factoradipocytechemokinediet-inducible regulatorGata3inflammationobesity

Identifiers

PMID42782745
PMCPMC13605690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.